Search Tag: Cancer imaging
2025 21 Oct
Cancer imaging and image-guided procedures are central to prevention, diagnosis and treatment, yet they carry a sizeable environmental load. Medical imaging is estimated to account for nearly 1% of the global carbon footprint. Environmental degradation increases cancer risk, disrupts care pathways and worsens outcomes, creating feedback between...Read more
2025 21 Oct
Cancer imaging and image-guided procedures are central to prevention, diagnosis and treatment, yet they carry a sizeable environmental load. Medical imaging is estimated to account for nearly 1% of the global carbon footprint. Environmental degradation increases cancer risk, disrupts care pathways and worsens outcomes, creating feedback between...Read more
2025 21 Oct
Cancer imaging and image-guided procedures are central to prevention, diagnosis and treatment, yet they carry a sizeable environmental load. Medical imaging is estimated to account for nearly 1% of the global carbon footprint. Environmental degradation increases cancer risk, disrupts care pathways and worsens outcomes, creating feedback between...Read more
2025 18 Sep
Gallbladder cancer is aggressive with poor prognosis, and curative surgery is often not feasible because most cases are diagnosed at advanced stages. For unresectable or metastatic disease, immunotherapy-based combinations have become first line. Reliable, non-invasive markers that can guide prognosis and treatment selection are therefore a priority....Read more
2025 13 Aug
Radiomics enables the extraction of quantitative features from medical images, offering detailed descriptors of tumour physiology that surpass visual interpretation. These radiomic features can be used to predict tumour heterogeneity, aggressiveness, treatment response and survival outcomes, thereby advancing precision medicine. For these predictions...Read more
2025 12 Jul
Achieving clear resection margins is critical in the surgical management of locally recurrent rectal cancer (LRRC), as it is closely linked to improved overall and disease-free survival. However, the feasibility of complete resection varies widely depending on tumour location and biological behaviour. A recent retrospective study published in...Read more
2025 01 Jul
Prostate cancer remains a major global health issue for men, and timely diagnosis is vital to ensuring effective treatment. Accurate segmentation of prostate cancer (PCa) lesions on MRI scans is a critical step in evaluating tumour extent, guiding biopsies and supporting treatment decisions. While magnetic resonance imaging (MRI) has proven effective...Read more
2025 17 May
Gastric cancer remains one of the leading causes of cancer-related deaths worldwide. For patients with locally advanced disease, particularly those classified as pathological T4 (pT4), accurate preoperative staging is vital to guide optimal treatment strategies. Current imaging methods, including conventional CT and endoscopic ultrasound, often...Read more
2025 24 Apr
Accurate and timely interpretation of radiology reports is critical for monitoring cancer progression and informing treatment decisions. However, the free-text nature and variability of these reports often pose challenges for oncologists, especially when dealing with large volumes of patient data. Recent advancements in artificial intelligence,...Read more
2025 24 Apr
Accurate and timely interpretation of radiology reports is critical for monitoring cancer progression and informing treatment decisions. However, the free-text nature and variability of these reports often pose challenges for oncologists, especially when dealing with large volumes of patient data. Recent advancements in artificial intelligence,...Read more
2025 10 Mar
The development of artificial intelligence in cancer research relies on access to extensive, high-quality imaging datasets. However, data fragmentation, heterogeneity and privacy concerns present significant challenges. The EUropean Federation for CAncer IMages (EUCAIM) initiative aims to overcome these obstacles by establishing a federated European...Read more
2025 10 Mar
Prostate cancer remains a significant health concern, with early and accurate detection crucial for improving patient outcomes. Magnetic resonance imaging (MRI) has become a valuable tool in identifying clinically significant prostate cancer (csPCa), particularly through the Prostate Imaging-Reporting and Data Systems (PI-RADS) scoring system....Read more
2024 14 Oct
Pancreatic cancer remains one of the deadliest cancers, characterised by poor survival rates and high resistance to chemotherapy. A significant component of this resistance stems from cellular senescence, a process where cells cease to divide but remain metabolically active, contributing to therapy resistance. Advances in molecular imaging, particularly...Read more
2024 19 Jul
FDG PET/CT is a well-established diagnostic tool widely used in oncology to detect and stage various cancers. It combines anatomical information from CT with functional imaging from PET, revealing disease extent better than CT or MRI alone. However, PET/CT has its limitations, such as poor soft tissue contrast and higher radiation exposure. These...Read more
2024 10 Jul
Early detection of liver metastases is critical for effective cancer management and long-term prognosis. Computed Tomography (CT) scans play a pivotal role in this process, relying on various reconstruction algorithms to convert raw data into usable images. The most common technique, Adaptive Statistical Iterative Reconstruction-V (ASiR-V), reduces...Read more
2024 10 Jul
Early detection of liver metastases is critical for effective cancer management and long-term prognosis. Computed Tomography (CT) scans play a pivotal role in this process, relying on various reconstruction algorithms to convert raw data into usable images. The most common technique, Adaptive Statistical Iterative Reconstruction-V (ASiR-V), reduces...Read more
2024 14 Jun
The European Society of Radiology (ESR) is pleased to announce the launch of a new Thematic Network dedicated to advancing precision medicine for cancer patients in Europe through AI-powered imaging. The network was launched following a successful proposal submission by the ESR and Cancer Image Europe (EUCAIM) on the EU Health Policy Platform....Read more
2020 29 Sep
POSTPONED DUE TO COVID-19 HEALTH CONCERNS UNTIL 2021. MORE DETAILS TO BE CONFIRMED Read more